Multifunctional fusion protein and application thereof
A fusion protein and multi-functional technology, applied in the biological field, can solve problems such as difficult expression, structural design problems, and cytotoxicity
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0114] The acquisition and optimization of embodiment 1 nucleotide sequence
[0115] The light chain and heavy chain amino acid sequence information of the multifunctional fusion protein CCI (or BCI) is selected from the public or self-developed Claudin18.2 (or B7H3) target monoclonal antibody sequence information, and the variable region and constant region of the sequence are obtained by analysis information. The variant sequence of the natural IL-15 and IL-15Rα complex was inserted into the amino acid sequence of one heavy chain, and the scFv sequence of the CD3 antibody was inserted at the corresponding position of the other heavy chain. According to needs, adjust the Fc of the amino acid sequence of the multifunctional fusion protein to other IgG types, such as IgG4, etc., and further design the required form of amino acid mutation in each heavy chain, thereby obtaining the amino acid sequence of the target multifunctional fusion protein, for:
[0116] Multifunctional f...
Embodiment 2
[0125] Embodiment 2 Gene synthesis and the construction of expression vector
[0126] The pcDNA3.1-G418 vector is used as a special vector for expressing the light chain and heavy chain of the multifunctional antibody. The pcDNA3.1-G418 vector contains the promoter CMVPromoter used for the heavy chain, the eukaryotic screening marker G418 tag and the prokaryotic screening tag Ampicilline. Gene synthesis obtained multifunctional fusion protein CCI and BCI antibody expression light chain and heavy chain nucleotide sequence, the vector and the target fragment were double-digested with HindIII and XhoI, after recovery, enzyme-linked by DNA ligase and transformed Escherichia coli competent cells DH5α, selected positive clones and carried out plasmid extraction and enzyme digestion verification, obtained the full-length first heavy chain, second heavy chain, first light chain and second light chain containing the fusion protein CCI Recombinant plasmids, respectively CCI-1 (the firs...
Embodiment 3
[0127] Example 3 plasmid extraction
[0128] According to the method described in "Molecular Cloning Experiment Guide" (2002, Science Press), the recombinant plasmids containing the above-mentioned genes of interest were transformed into Escherichia coli competent cells DH5α, and the transformed bacteria were coated on a medium containing 100 μg / mL ampicillin. Culture on LB plates, select plasmid clones and culture them in liquid LB medium, shake the bacteria at 260rpm for 14 hours, extract plasmids from the endotoxin-free plasmid extraction kit, dissolve them in sterile water, and measure the concentration with a nucleic acid protein quantifier.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com